Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A germinoma arising from the brain during childhood.
Biomarker and diagnostic research for childhood brain germinoma has been reported in the published literature.
No clinical trials have been registered for childhood brain germinoma.
40 publications have been identified in PubMed for childhood brain germinoma. Research spans Case Report / Case Series (38%), Epidemiology / Natural History (21%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 15 | 38% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:47 AM UTC
8 |
21% |
Research summaries | 6 | 15% |
Clinical study results | 4 | 10% |
Testing and diagnosis research | 3 | 8% |
Laboratory research | 3 | 8% |
Poon SWY (2026). [PMID: 41074639](https://pubmed.ncbi.nlm.nih.gov/41074639/). *Pediatric blood & cancer*. [Basic Science / Preclinical]
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Vitulli F (2026). [PMID: 41832330](https://pubmed.ncbi.nlm.nih.gov/41832330/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Review / Meta-Analysis]
Saliba A (2026). [PMID: 41710768](https://pubmed.ncbi.nlm.nih.gov/41710768/). *Frontiers in child and adolescent psychiatry*. [Diagnostic / Biomarker]
Miller HK (2026). [PMID: 42111021](https://pubmed.ncbi.nlm.nih.gov/42111021/). *Neurooncol Pract*. [Case Report / Case Series]
Laprie A (2026). [PMID: 42114599](https://pubmed.ncbi.nlm.nih.gov/42114599/). *Radiother Oncol*. [Clinical Trial Publication]
Wang YF (2025). [PMID: 38821737](https://pubmed.ncbi.nlm.nih.gov/38821737/). *Journal of the Formosan Medical Association = Taiwan yi zhi*. [Epidemiology / Natural History]
Song K (2025). [PMID: 40762663](https://pubmed.ncbi.nlm.nih.gov/40762663/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Case Report / Case Series]
Ríos D (2025). [PMID: 40493821](https://pubmed.ncbi.nlm.nih.gov/40493821/). *Biomedica : revista del Instituto Nacional de Salud*. [Case Report / Case Series]
Dong Y (2025). [PMID: 41175415](https://pubmed.ncbi.nlm.nih.gov/41175415/). *The Journal of international medical research*. [Case Report / Case Series]
AI-curated news mentioning childhood brain germinoma
Updated Sep 8, 2026
BrainChild secures $116 million in funding to advance its CAR-T cell therapy targeting rare childhood brain cancers into mid-stage testing. The startup, originating from Seattle Children’s Hospital research, aims to address a critical need in pediatric oncology.
An experimental immune-cell therapy shows promise in treating aggressive childhood brain tumors, with several children remaining cancer-free years after treatment in an early-stage trial. This breakthrough offers hope for families facing limited options against these deadly cancers.